| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
CHEMGENEX PHARMACEUTICALS LTD (CXS)
Stock Code: CXS
Listing Date: 1986-07-10 00:00:00
Website: http://www.chemgenex.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Biotechnology research and development company
Address:
199 Moorabool Street, Level 4
Geelong
VIC 3220
Phone: 03 5223 9900
Fax: 03 5229 0100
Executives & Directors
Mr Brett Heading, Non Exec. Chairman
Dr Adam R Craig, Vice President
Prof. Gregory Collier, Managing Director, CEO
Mr Jean-Luc Tetard, Director
Mr Dennis Brown, Executive Director
Mr Elmar Schnee, Non Exec. Director
Dr Geoff Brooke, Non Exec. Director
Mr Daniel Janney, Non Exec. Director
Mr Donald Santel, Non Exec. Director
Dr Julie Cherrington, Non Exec. Director
Dr George Morstyn, Non Exec. Director
Mr Eric Patrick Merrigan, CFO
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
Excellence in Biotechnology Investment - Prof Greg Collier, CEO, ChemGenex Pharmaceuticals Ltd
|
|
Wed, 23 Apr 2008 02:00PM |
| Annual General Meeting | Wed, 26 Nov 2008 12:00PM |
|
| Full Year Results | Wed, 1 Oct 2008 | |
| EGM | Tue, 22 Jul 2008 11:00AM |
|
| EGM | Wed, 26 Mar 2008 04:30PM |
|
| Interim Results | Wed, 27 Feb 2008 | |
| Record Date | Wed, 12 Dec 2007 | |
| Ex Div Date | Thu, 6 Dec 2007 | |
| Annual General Meeting | Wed, 28 Nov 2007 03:00PM |
|
| Full Year Results | Fri, 31 Aug 2007 | |
| Interim Results | Fri, 23 Feb 2007 | |
| Annual General Meeting | Wed, 29 Nov 2006 04:30PM |
|
| Full Year Results | Tue, 29 Aug 2006 | |
| EGM | Fri, 16 Jun 2006 03:00PM |
|
| Interim Results | Fri, 10 Mar 2006 | |
| Annual General Meeting | Wed, 16 Nov 2005 11:00AM |
CHEMGENEX PHARMACEUTICALS LTD (CXS)
| Change in substantial holding | Tue, 18 Nov 2008 |
| Notice of Annual General Meeting/Proxy Form | Tue, 21 Oct 2008 |
| Completion of SPP | Mon, 13 Oct 2008 |
| Appendix 3B | Mon, 13 Oct 2008 |
| Annual Report to shareholders | Wed, 1 Oct 2008 |
| Change in substantial holding | Thu, 25 Sep 2008 |
| s 708A (5) (e) Disclosure Document | Tue, 23 Sep 2008 |
| SPP Booklet | Mon, 22 Sep 2008 |
| Mail out of SPP details to eligible shareholders | Mon, 22 Sep 2008 |
| Appendix 3B | Wed, 17 Sep 2008 |
| Placement | Wed, 17 Sep 2008 |
| Trading Halt Request | Mon, 15 Sep 2008 |
| Trading Halt | Fri, 12 Sep 2008 |
| Trading Halt Request | Fri, 12 Sep 2008 |
| Company Address Details | Wed, 10 Sep 2008 |
| Preliminary Final Report | Fri, 29 Aug 2008 |
| Correction Preliminary Final Report | Fri, 29 Aug 2008 |
| Director Appointment | Tue, 5 Aug 2008 |
| Initial Director`s Interest Notice | Tue, 5 Aug 2008 |
| Ceasing to be a substantial holder | Wed, 30 Jul 2008 |
| Change in substantial holding | Tue, 29 Jul 2008 |
| Change in substantial holding | Mon, 28 Jul 2008 |
| Becoming a substantial holder | Fri, 25 Jul 2008 |
| Change in substantial holding | Fri, 25 Jul 2008 |
| Change in substantial holding | Thu, 24 Jul 2008 |
| Results of Meeting | Wed, 23 Jul 2008 |
| Appendix 3B | Wed, 23 Jul 2008 |
| Response to ASX Price Query | Wed, 23 Jul 2008 |
| Change in substantial holding | Wed, 23 Jul 2008 |
| Initiates Rolling NDA Submission for Omacetaxine | Tue, 1 Jul 2008 |
| Notice of Extraordinary General Meeting/Proxy Form | Tue, 17 Jun 2008 |
| Data from Clinical Investigators at EHA Congress | Mon, 16 Jun 2008 |
| Correction to Appendix 3B of June 10, 2008 | Fri, 13 Jun 2008 |
| ChemGenex Acquires Full Control of Omacetaxine | Tue, 10 Jun 2008 |
| Appendix 3B | Tue, 10 Jun 2008 |
| Updated clinical data on omacetaxine presented at conference | Tue, 3 Jun 2008 |
| ATO Class Ruling on Demerger | Mon, 12 May 2008 |
| Updates Omacetaxine Mechanism at International Conference | Tue, 15 Apr 2008 |
| Confirms NDA Rolling Submission after meeting with FDA | Mon, 14 Apr 2008 |
| Clinical trial data presented at international conference | Tue, 1 Apr 2008 |
| Results of Meeting | Thu, 27 Mar 2008 |
| Appendix 3B | Thu, 27 Mar 2008 |
| Change of Director`s Interest Notice | Thu, 27 Mar 2008 |
| Initiates phase 2 clinical trial of omacetaxine in AML | Tue, 11 Mar 2008 |
| Half Yearly Report and Accounts | Wed, 27 Feb 2008 |
| Notice of Extraordinary General Meeting/Proxy Form | Tue, 19 Feb 2008 |
| Initial Director`s Interest Notice | Fri, 15 Feb 2008 |
| Company to Present at BioCEO | Wed, 6 Feb 2008 |
| Mail Out of Holding Statements | Tue, 18 Dec 2007 |
| Omacetaxine Effective in Killing Leukemic Stem Cells | Tue, 11 Dec 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.